专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

61. 发明申请

US20130161461A1 CONNECTING STRUCTURE 有权
标题翻译：连接结构
公开(公告)号：US20130161461A1
公开(公告)日：2013-06-27
申请号：US13585893
申请日：2012-08-15
申请人： CHE-YU CHOU , Qun Huang , Tai-Shan Zhu , Tao Jiang , Wen-Chih Lan , Jun-Liang Zhang , Ji-Bing Guo , Hua-Yong Wang , Zhou Chen , Hai-Qian Ge , Wei-Wei Yu , Zhi-Jun Shi
发明人： CHE-YU CHOU , Qun Huang , Tai-Shan Zhu , Tao Jiang , Wen-Chih Lan , Jun-Liang Zhang , Ji-Bing Guo , Hua-Yong Wang , Zhou Chen , Hai-Qian Ge , Wei-Wei Yu , Zhi-Jun Shi
IPC分类号： F16M13/02 , F16B45/00
CPC分类号： G06F1/1656 , G06F3/0202 , G06F3/03543 , H04M1/0254
摘要： A connecting structure received in a main device for connecting an auxiliary apparatus. The connecting structure includes a retracting part formed on a bottom board of the main device and close to a sidewall of the main device and a clamping part. The clamping part is pivotablly mounted on the bottom board and pivotally connected to the retracting part. The retracting part drives the clamping part to extend out of the main device via an opening defined on the sidewall for connecting the auxiliary apparatus when the auxiliary apparatus needs to be mounted on the main device. The retracting part retracts the clamping part into the main device when the auxiliary apparatus is unmounted from the main device.
摘要翻译：一种连接结构，被容纳在用于连接辅助设备的主设备中。连接结构包括形成在主装置的底板上并且靠近主装置的侧壁和夹紧部分的缩回部分。夹紧部分可枢转地安装在底板上并枢转地连接到缩回部分。当辅助装置需要安装在主装置上时，缩回部件通过限定在侧壁上的开口驱动夹紧部件延伸出主装置以连接辅助装置。当辅助设备从主设备卸下时，缩回部件将夹紧部件缩回到主设备中。

62. 发明申请

US20120116086A1 Sinomenine Derivatives and Processes for their Synthesis 有权
标题翻译：中药衍生物及其合成方法
公开(公告)号：US20120116086A1
公开(公告)日：2012-05-10
申请号：US13352668
申请日：2012-01-18
申请人： Peter X. Wang , Tao Jiang , Gary L. Cantrell , David W. Berberich , Bobby N. Trawick , Subo Liao , John Brandt
发明人： Peter X. Wang , Tao Jiang , Gary L. Cantrell , David W. Berberich , Bobby N. Trawick , Subo Liao , John Brandt
IPC分类号： C07D489/02
CPC分类号： C07D221/28 , C07D489/02
摘要： The invention generally provides processes and intermediate compounds useful for the production of sinomenine derivatives. In particular, the process may encompass synthetic routes for the production of (+)-sinomenine derivatives and their intermediates.
摘要翻译：本发明通常提供可用于生产青藤碱衍生物的方法和中间体化合物。特别地，该方法可以包括用于生产（+） - 青藤碱衍生物及其中间体的合成路线。

63. 发明授权

US08017777B2 Process for the preparation of buprenorphine and derivatives for buprenorphine 有权
标题翻译：丁丙诺啡和丁丙诺啡衍生物的制备方法
公开(公告)号：US08017777B2
公开(公告)日：2011-09-13
申请号：US12316861
申请日：2008-12-17
申请人： Peter X. Wang , Tao Jiang , Gary L. Cantrell , David W. Berberich , Bobby N. Trawick , Subo Liao
发明人： Peter X. Wang , Tao Jiang , Gary L. Cantrell , David W. Berberich , Bobby N. Trawick , Subo Liao
IPC分类号： C07D489/12 , C07D489/02
CPC分类号： C07D489/12
摘要： The invention generally provides processes for the production of buprenophine and derivatives of buprenorphine. In particular, the process may encompass synthetic routes for the production of buprenorphine or derivatives of buprenorphine from norhydromorphone or derivatives of norhydromorphone.
摘要翻译：本发明通常提供了生产丁丙诺啡和丁丙诺啡衍生物的方法。特别地，该方法可以包括用于生产丁丙诺啡或来自去甲低吗啡酮或去唾液酸转移酶的衍生物的丁丙诺啡衍生物的合成路线。

64. 发明申请

US20100323949A1 ERYTHROPOIETIN MIMETIC PEPTIDE DERIVATIVE AND ITS PHARMACEUTICAL SALTS, THE PREPARATION AND USES THEREOF 有权
标题翻译：孕激素衍生物及其制药盐，其制备及其用途
公开(公告)号：US20100323949A1
公开(公告)日：2010-12-23
申请号：US12747818
申请日：2008-11-24
申请人： Aifeng Lü , Changan Sun , Tao Jiang , Wentao Wu , Yali Wang
发明人： Aifeng Lü , Changan Sun , Tao Jiang , Wentao Wu , Yali Wang
IPC分类号： A61K38/22 , C07K7/08 , C07K14/00 , A61K38/10 , A61K38/16 , A61P11/00 , A61P35/00 , A61P31/18 , A61P25/00
CPC分类号： C07K14/505 , A61K47/55 , A61K47/60
摘要： What is provided is EPO mimetic peptide derivatives defined as formula (I) and their pharmaceutical salts, the preparation thereof, wherein R1, R2, R3, R4, R5, n1, n2 are defined as described in description. A composition comprising of an EPO mimetic peptide derivative defined as formula (I) and its pharmaceutical salt. The uses of the derivatives and their pharmaceutical salts, as well as the uses of the compositions described above in treatment of diseases characterized by a deficiency of EPO or a low or defective red blood cell population. R1—R2—(CH2)n1—R3—(CH2)n2—R4—R5 (I)
摘要翻译：提供的定义为式（I）的EPO模拟肽衍生物及其药物盐及其制备方法，其中R1，R2，R3，R4，R5，n1，n2如描述中所述定义。包含由式（I）定义的EPO模拟肽衍生物及其药物盐的组合物。衍生物及其药物盐的用途，以及上述组合物在治疗由EPO缺乏或低或有缺陷的红细胞群体特征的疾病的用途中的用途。 R1-R2-（CH2）n1-R3-（CH2）n2-R4-R5（I）

65. 发明申请

US20100261907A1 Preparation of Saturated Ketone Morphinan Compounds 有权
标题翻译：饱和酮吗啡喃化合物的制备
公开(公告)号：US20100261907A1
公开(公告)日：2010-10-14
申请号：US12757098
申请日：2010-04-09
申请人： Peter X. Wang , Tao Jiang , David W. Berberich , Narayanasamy Gurusamy , Catherine K. Jung
发明人： Peter X. Wang , Tao Jiang , David W. Berberich , Narayanasamy Gurusamy , Catherine K. Jung
IPC分类号： C07D489/00
CPC分类号： C07D489/04 , C07D489/02
摘要： The present invention provides processes for the preparation of saturated ketone morphinan compounds. In particular, the invention provides processes for the conversion of a morphinan comprising an allyl alcohol ring moiety into a morphinan comprising a saturated ketone ring moiety by an isomerization reaction catalyzed by an inorganic salt of a late transition metal.
摘要翻译：本发明提供了制备饱和酮吗啡喃化合物的方法。特别地，本发明提供了通过由后过渡金属的无机盐催化的异构化反应将包含烯丙醇环部分的吗啡喃转化成包含饱和酮环部分的吗啡喃的方法。

66. 发明授权

US07750021B2 Immunosuppressant compounds and compositions 有权
标题翻译：免疫抑制剂化合物和组合物
公开(公告)号：US07750021B2
公开(公告)日：2010-07-06
申请号：US12180479
申请日：2008-07-25
申请人： Yuan Mi , Shifeng Pan , Nathanael Schiander Gray , Wenqi Gao , Yi Fan , Tao Jiang
发明人： Yuan Mi , Shifeng Pan , Nathanael Schiander Gray , Wenqi Gao , Yi Fan , Tao Jiang
IPC分类号： A61K31/343 , A61K31/352 , A61K31/396 , A61K31/4035 , A61K31/404 , A61K31/416 , A61K31/423 , A61K31/428 , A61K31/4365 , A61K31/437 , C07D263/56 , C07D277/64 , C07D231/56 , C07D209/04 , C07D513/04 , C07D493/04
CPC分类号： C07D333/58 , C07D261/20 , C07D409/06 , C07D471/04 , C07D473/00 , C07D513/04
摘要： The present invention relates to immunosuppressant, process for their production, their uses and pharmaceutical compositions containing them. The invention provides a novel class of compounds useful in the treatment or prevention of diseases or disorders mediated by lymphocyte interactions, particularly diseases associated with EDG receptor mediated signal transduction.
摘要翻译：本发明涉及免疫抑制剂，其生产方法及其用途和含有它们的药物组合物。本发明提供了一类新颖的化合物，其可用于治疗或预防由淋巴细胞相互作用介导的疾病或病症，特别是与EDG受体介导的信号转导相关的疾病。

67. 发明申请

US20100081818A1 Process for the Preparation of 6-Alpha-Hydroxy-N-Alkylated Opiates 有权
标题翻译： 6-α-羟基-N-烷基化的鸦片剂的制备方法
公开(公告)号：US20100081818A1
公开(公告)日：2010-04-01
申请号：US12630192
申请日：2009-12-03
申请人： Christopher W. Grote , Peter X. Wang , Tao Jiang , Gary L. Cantrell , Frank W. Moser , Catherine E. Thomasson
发明人： Christopher W. Grote , Peter X. Wang , Tao Jiang , Gary L. Cantrell , Frank W. Moser , Catherine E. Thomasson
IPC分类号： C07D489/00
CPC分类号： C07D489/02 , Y02P20/55
摘要： The present invention is directed to the preparation of 6-hydroxy morphinans having formula (II) or N-alkylated 6-hydroxy morphinans having formula (III).
摘要翻译：本发明涉及具有式（II）的6-羟基吗啡烷或具有式（III）的N-烷基化的6-羟基吗啡喃的制备。

68. 发明授权

US07660529B2 System and method for providing failure protection in optical networks 有权
标题翻译：在光网络中提供故障保护的系统和方法
公开(公告)号：US07660529B2
公开(公告)日：2010-02-09
申请号：US11517815
申请日：2006-09-08
申请人： Guo Wei , Xuliang Zhang , Tao Jiang , Jun Zhao , Wei Huang , Jun Chen , Yuntao Wang , Huafeng Lin , Feng Wang
发明人： Guo Wei , Xuliang Zhang , Tao Jiang , Jun Zhao , Wei Huang , Jun Chen , Yuntao Wang , Huafeng Lin , Feng Wang
IPC分类号： H04B10/08 , H04B10/04 , H04J14/02
CPC分类号： H04J14/0297 , H04B10/032 , H04J14/0226 , H04J14/0246 , H04J14/025 , H04J14/0282
摘要： A system and method for transmitting an optical signal. The system includes a first optical transmitter capable of transmitting a first optical signal under one or more first operating conditions, and the first optical signal corresponds to a first wavelength. Additionally, the system includes a second optical transmitter capable of transmitting a second optical signal under one or more second operating conditions, and the second optical signal corresponds to a second wavelength. Moreover, the system includes an optical multiplexer coupled to the first optical transmitter and the second optical transmitter and capable of generating a multiplexed optical signal, a detection component configured to determine at least whether the first optical transmitter satisfies one or more predetermined conditions, and a tunable optical transmitter capable of transmitting a third optical signal. The third optical signal corresponds to a third wavelength.
摘要翻译：一种用于发送光信号的系统和方法。该系统包括能够在一个或多个第一操作条件下发送第一光信号的第一光发射机，第一光信号对应于第一波长。此外，该系统包括能够在一个或多个第二操作条件下发送第二光信号的第二光发射机，第二光信号对应于第二波长。此外，该系统包括耦合到第一光发射机和第二光发射机并且能够产生复用光信号的光复用器，检测组件被配置为至少确定第一光发射机是否满足一个或多个预定条件，以及可调谐光发射机，能够发送第三光信号。第三光信号对应于第三波长。

69. 发明申请

US20090157356A1 Hardware test and diagnosis system and method 失效
标题翻译：硬件测试与诊断系统及方法
公开(公告)号：US20090157356A1
公开(公告)日：2009-06-18
申请号：US12288099
申请日：2008-10-15
申请人： Tao Jiang , Xiaohua Xie
发明人： Tao Jiang , Xiaohua Xie
IPC分类号： G06F15/00
CPC分类号： G06F11/27
摘要： There is provided a hardware test and diagnosis system comprising a diagnostic computer and a test device. The test device comprises a peripheral chipset and a baseband controller configured to execute an agent software. The agent software is configured to be coupled to the diagnostic computer, and the agent software is further configured to be coupled to the peripheral chipset of the test device. The agent software is further configured to provide a virtual channel between the diagnostic computer and the peripheral chipset. In one embodiment, the agent software comprises a driver configured for communication with the peripheral chipset, and is further configured to receive additional software from the diagnostic computer. In another embodiment, the agent software is further configured to be embedded in a boot code of the test device.
摘要翻译：提供了包括诊断计算机和测试装置的硬件测试和诊断系统。测试设备包括外围芯片组和被配置为执行代理软件的基带控制器。代理软件被配置为耦合到诊断计算机，并且代理软件被进一步配置为耦合到测试设备的外围芯片组。代理软件还被配置为在诊断计算机和外围芯片组之间提供虚拟通道。在一个实施例中，代理软件包括被配置为与外围芯片组通信的驱动器，并且还被配置为从诊断计算机接收附加软件。在另一个实施例中，代理软件还被配置为嵌入在测试设备的引导代码中。

70. 发明申请

US20090156815A1 N-demethylation of N-methyl morphinans 有权
标题翻译： N-甲基吗啡喃的N-去甲基化
公开(公告)号：US20090156815A1
公开(公告)日：2009-06-18
申请号：US12316821
申请日：2008-12-17
申请人： Peter X. Wang , Tao Jiang , Gary L. Cantrell , David W. Berberich
发明人： Peter X. Wang , Tao Jiang , Gary L. Cantrell , David W. Berberich
IPC分类号： C07D489/02
CPC分类号： C07D489/02
摘要： The present invention provides a synthetic process for the N-demethylation of N-methyl morphinans. In particular, the invention provides improved synthetic methods for the preparation of N-demethylated morphinan compounds that may be employed as starting materials, for example, commonly available N-methyl opiates such as oripavine and thebaine, and C(3)-protected hydroxy derivatives of oripavine.
摘要翻译：本发明提供了N-甲基吗啡喃的N-去甲基化的合成方法。特别地，本发明提供了用于制备可用作起始原料的N-去甲基化吗啡喃化合物的改进的合成方法，例如常用的N-甲基阿片剂，例如奥利磷和蒂巴因，以及C（3）保护的羟基衍生物的oripavine。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式